Curanex Pharmaceuticals Inc (CURX) stock
CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70−0.00 (-0.00%)
Close on Nov 18, 2026Market cap $7.37MP/E –Yield –
Curanex Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Curanex Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2026 was -$4.25M. For fiscal 2025 it was -$10.48M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.48M | – |
| FY2024 | Dec 31, 2024 | -$555.58K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.36M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.08M | – |
| Q1 FY2026 | Mar 31, 2026 | -$954.56K | – |
| Q4 FY2025 | Dec 31, 2025 | -$857.40K | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.19M | – |
| Q2 FY2025 | Jun 30, 2025 | -$290.08K | – |
| Q1 FY2025 | Mar 31, 2025 | -$149.95K | – |
| Q4 FY2024 | Dec 31, 2024 | -$95.43K | – |
| Q3 FY2024 | Sep 30, 2024 | -$129.94K | – |
See a number that looks wrong?